Publications by authors named "Christopher Woo"

Claim this Profile
C
Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
William F Fearon, Kosei Terada, Kuniaki Takahashi, Anette Skoda, Helen I Luikart, Christopher Woo

Circulation· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preemptive anticoagulation of pulmonary embolism.
Christopher Woo, Wei Sun, Paul Thein, Mae Yi Chong, Ethan Tan

Intern Med J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
Alexander T Sandhu, Shun Kohsaka, Shoutzu Lin, Christopher Y Woo, Mary K Goldstein

Am Heart J· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irradiation Enhances the Ability of Monocytes as Nanoparticle Carrier for Cancer Therapy.
Pei-Shin Jiang, Ching-Fang Yu, Chia-Yi Yen, Christopher William Woo, Shao-Hua Lo

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure.
Christopher Y Woo, Erika J Strandberg, Michelle D Schmiegelow, Allison L Pitt, Mark A Hlatky

Ann Intern Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.
Takuya Osada, Christopher Y Woo, Matthew McKinney, Xiao Yi Yang, Gangjun Lei

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapeutic targeting of Wilms' tumor protein.
Yalonda Hutchings, Takuya Osada, Christopher Y Woo, Timothy M Clay, H Kim Lyerly

Curr Opin Mol Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based immunotherapy.
Takuya Osada, Timothy M Clay, Christopher Y Woo, Michael A Morse, H Kim Lyerly

Int Rev Immunol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent clinical progress in virus-based therapies for cancer.
Christopher Y Woo, Takuya Osada, Timothy M Clay, H Kim Lyerly, Michael A Morse

Expert Opin Biol Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of natural killer cell function in dendritic cell-based vaccines.
Christopher Y Woo, Timothy M Clay, H Kim Lyerly, Michael A Morse, Takuya Osada

Expert Rev Vaccines· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis